Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

Trends & Developments in Life Sciences: Insights from Top Experts in Investment & Innovation

  • Published March 28, 2023 5:18AM UTC
  • Publisher Jade Miguel
  • Categories Capital Insights

Covid-19 has highlighted the importance of health and spurred remarkable advancements in the Life Sciences & Genomics sector.

Join Leslie Chong, Hsien Hui Tong, Victoria Gordon, and Kelly Constable as they discuss the impact of Covid-19 on Life Sciences investment, current trends, and opportunities for the sector in the next 1-2 years.

Moderated by Glen Cross, Director of Horizon 3 Biotech Fund, this video is a must-watch for investors and innovators in the Life Sciences space.

YouTube player

#VentureCapital #Innovation #WholesaleInvestor

Capital Insights
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market

Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.

Capital Insights
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker

Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]

Join over 45,000+ sophisticated investors

Join Now